EUVIMEDEUVIMED entdecken
Crossref

Predicting the Onset of Hepatitis B Virus–Related Acute-on-Chronic Liver Failure

Jinjin Luo, Xi Liang, Jiaojiao Xin, Jiaqi Li, Peng Li, Qian Zhou, Shaorui Hao, Huafen Zhang, Yingyan Lu, Tianzhou Wu, Lingling Yang, Jiang Li und 15 weitere

Clinical Gastroenterology and Hepatology · 2023-03 · 21 (3) · 681-693

DOI: 10.1016/j.cgh.2022.03.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-03. Verfasst von Jinjin Luo und 26 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical …. Hauptthemen laut MEDLINE: End Stage Liver Disease, Hepatitis B, Chronic, Acute-On-Chronic Liver Failure, Hepatitis B. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Acute-on-chronic liver failure (ACLF) is a life-threatening syndrome with rapid progression. This study aimed to develop and validate a prognostic score to predict the onset of ACLF in hepatitis B virus (HBV) etiology. METHODS: The prospective clinical data of 1373 patients with acute deterioration of HBV-related chronic liver disease were used to identify clinical characteristics and develop a prognostic score for the onset of ACLF. RESULTS: Of the patients assessed using the Chinese Group on the Study of Severe Hepatitis B (COSSH)-ACLF criteria, 903 patients with non-ACLF at admission (1 received transplantation at 5 days) were stratified: 71 with progression to ACLF and 831 without progression to ACLF at 7 days. Four predictors (total bilirubin, international normalized ratio, alanine aminotransferase, and ferritin) were associated significantly with ACLF onset at 7 days. The COSSH-onset-ACLF score was constituted as follows: (0.101 × ln [alanine aminotransferase] + 0.819 × ln [total bilirubin] + 2.820 × ln [international normalized ratio] + 0.016 × ln [ferritin]). The C-indexes of the new score for 7-/14-/28-day onset (0.928/0.925/0.913) were significantly higher than those of 5 other scores (Chronic Liver Failure Consortium ACLF development score/Model for End-stage Liver Disease score/Model for End-stage Liver Disease sodium score/COSSH-ACLF score/Chronic liver failure Consortium ACLF score; all P < .001). The improvement in predictive errors, time-dependent receiver operating characteristic, probability density function evaluation, and calibration curves of the new score showed the highest predictive value for ACLF onset at 7/14/28 days. Risk stratification of the new score showed 2 strata with high and low risk (≥6.3/

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

End Stage Liver DiseaseHepatitis B, ChronicAcute-On-Chronic Liver FailureHepatitis BHumansHepatitis B virusProspective StudiesAlanine TransaminasePrognosisRetrospective StudiesSeverity of Illness IndexBilirubinROC Curve

Stichwörter der Autor:innen

ACLFC-IndexHBVPrognostic Score

Substanzen

Alanine TransaminaseBilirubin

Autor:innen und Institutionen

  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, The First Affiliated Hospital, Zhejian…
  • Precision Medicine Center, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.
  • Key Laboratory of Cancer Prevention and Therapy Combining Traditional Chinese and Western Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, China.
  • Department of Gastroenterology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Department of Infectious Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Senior Department of Hepatology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.

Zitieren

APA

Luo, J., Liang, X., Xin, J., Li, J., Li, P., Zhou, Q., Hao, S., Zhang, H., Lu, Y., Wu, T., Yang, L., Li, J., Li, T., Ren, K., Guo, B., Zhou, X., Chen, J., He, L., Yang, H., …, & Chinese Group on the Study of Severe Hepatitis B (COSSH) (2023). Predicting the Onset of Hepatitis B Virus–Related Acute-on-Chronic Liver Failure. Clinical Gastroenterology and Hepatology, 21(3), 681-693. https://doi.org/10.1016/j.cgh.2022.03.016

Vancouver

Luo J, Liang X, Xin J, Li J, Li P, Zhou Q, et al. Predicting the Onset of Hepatitis B Virus–Related Acute-on-Chronic Liver Failure. Clinical Gastroenterology and Hepatology. 2023;21(3):681-693. doi:10.1016/j.cgh.2022.03.016

BibTeX
@article{Luo2023,
  author = {Luo, Jinjin and Liang, Xi and Xin, Jiaojiao and Li, Jiaqi and Li, Peng and Zhou, Qian and Hao, Shaorui and Zhang, Huafen and Lu, Yingyan and Wu, Tianzhou and Yang, Lingling and Li, Jiang and Li, Tan and Ren, Keke and Guo, Beibei and Zhou, Xingping and Chen, Jiaxian and He, Lulu and Yang, Hui and Hu, Wen and You, Shaoli and Xin, Shaojie and Jiang, Jing and Shi, Dongyan and Chen, Xin and Li, Jun and Chinese Group on the Study of Severe Hepatitis B (COSSH), Chinese Group on the Study of Severe Hepatitis B (COSSH)},
  title = {Predicting the Onset of Hepatitis B Virus–Related Acute-on-Chronic Liver Failure},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  volume = {21},
  number = {3},
  pages = {681--693},
  doi = {10.1016/j.cgh.2022.03.016}
}
Kostenlos starten →